L. Becker Hewes
Chief Medical Officer · Damora Therapeutics, Inc.
Individual
- 2025
- Jan 8, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies L. Becker Hewes files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jennifer Jarrett - $253K in DMRA purchases and sales in the last 12 months
- Hans T. Schambye - $15K in DMRA purchases and sales in the last 12 months
- Garrett Winslow - $13K in DMRA purchases and sales in the last 12 months
- Lori Firmani - $3K in DMRA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is L. Becker Hewes?
L. Becker Hewes is a corporate insider, tracked as Chief Medical Officer of Damora Therapeutics, Inc. (DMRA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did L. Becker Hewes last file a Form 4?
The most recent primary Form 4 on record is dated 8 January 2026, one of 2 filings going back to 2025.
